insights

Learn about cutting-edge science
and gain life-enhancing insights

Investors hope psychedelics are the new cannabis. Are they high?

In January atai Life Sciences, the German biotech company he founded last year, acquired a majority stake in Perception Neuroscience, a biopharmaceutical firm from New York which is developing a medication for pyschiatric conditions like depression from the drug, which is illegal in parts of the world.

Read More »

Follow us
on Social Media